Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease. Santella C, Bitton A, Filliter C, Bessissow T, et al. Inflamm Bowel Dis 2021 May 17. pii: 6276941. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Santella C, Bitton A, Filliter C, Bessissow T, et al. Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021 May 17. pii: 6276941. doi: 10.1093.
PMID: 33999136